Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience
Surgery · 2025
DOI: 10.1016/j.surg.2025.109331 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgery, 2025. Verfasst von Yejong Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republi…. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Palliative Care, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
BACKGROUND: The benefits of palliative minimally invasive distal pancreatectomy for patients with unexpectedly metastatic pancreatic ductal adenocarcinoma have not been previously studied. This retrospective study compared the outcomes of palliative minimally invasive distal pancreatectomy with those of minimally invasive biopsy in these patients. METHODS: We reviewed the records of 46 patients with unexpected metastasis of left-sided pancreatic ductal adenocarcinoma that were discovered during surgery between 2005 and 2019. Nineteen patients underwent palliative resection (minimally invasive distal pancreatectomy group), whereas 27 patients underwent only minimally invasive biopsy (minimally invasive biopsy group). Demographic, clinical, and operative data, as well as survival rates, were compared between the 2 groups. RESULTS: Major complications (Clavien-Dindo grade ≥3) were comparable between the 2 groups (11.8% vs 5.6%; P = .603). Postoperative chemotherapy was administered to 84.2% of the minimally invasive distal pancreatectomy group and 77.8% of the minimally invasive biopsy group (P = .716). The minimally invasive distal pancreatectomy group had a higher completion rate of first-line palliative chemotherapy (42.9% vs 8.7%; P = .007) and a higher 2-year survival rate (36.8% vs 18.8%; P = .004). In multivariate analysis, survival was associated with completion of first-line chemotherapy (hazard ratio: 2.962; P = .003) and maintenance chemotherapy for over 12 months (hazard ratio: 2.339; P = .010). Gastric outlet obstruction was less prevalent in the minimally invasive distal pancreatectomy group (5.3% vs 25.9%, P = .037). CONCLUSION: Palliative minimally invasive distal pancreatectomy may improve survival and facilitate the continuation of chemotherapy in selected patients with unexpected metastatic pancreatic ductal adenocarcinoma. However, the small sample size and potential selection bias limit the generalizability of these findings. Larger, prospective, multicenter studies are needed to confirm the role of minimally invasive distal pancreatectomy and to establish optimal management strategies for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Convergence Medicine, Asan Institute for Lif…
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, BK21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: drksc@amc.seoul.kr.
Förderung
- Asan Institute for Life Sciences, Asan Medical Center
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Park, Y., Hwang, D. W., Lee, J. H., Song, K. B., Jun, E., Lee, W., Sung, M. K., & Kim, S. C. (2025). Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience. Surgery. https://doi.org/10.1016/j.surg.2025.109331
Vancouver
Park Y, Hwang DW, Lee JH, Song KB, Jun E, Lee W, et al. Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience. Surgery. 2025. doi:10.1016/j.surg.2025.109331
BibTeX
@article{Park2025,
author = {Park, Yejong and Hwang, Dae Wook and Lee, Jae Hoon and Song, Ki Byung and Jun, Eunsung and Lee, Woohyung and Sung, Min Kyu and Kim, Song Cheol},
title = {Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience},
journal = {Surgery},
year = {2025},
doi = {10.1016/j.surg.2025.109331}
}
EUVIMED